Jonathan Grossman
Neurology · Valparaiso, INNPI 1093210114
Payments from drug & device makers
Across 118 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$555
- Pfizer$143
- EMD Serono, Inc.$139
- Sanofi$128
- Lilly USA, LLC$106
- Argenx US, Inc.$95
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,205100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $555 |
| Pfizer | 13 | $143 |
| EMD Serono, Inc. | 7 | $139 |
| Sanofi | 2 | $128 |
| Lilly USA, LLC | 5 | $106 |
| Argenx US, Inc. | 4 | $95 |
| Novartis | 4 | $94 |
| Acadia Pharmaceuticals Inc | 4 | $89 |
| Jazz Pharmaceuticals Inc. | 2 | $65 |
| UCB, Inc. | 2 | $64 |
| Inspire Medical Systems, Inc. | 2 | $57 |
| Genentech USA, Inc. | 2 | $54 |
| TG Therapeutics, Inc. | 2 | $53 |
| Aucta Pharmaceuticals, Inc. | 2 | $50 |
| Tanabe Pharma America, Inc. | 2 | $46 |
| Amneal Pharmaceuticals LLC | 2 | $40 |
| Neurocrine Biosciences, Inc. | 2 | $38 |
| Neurelis, Inc. | 2 | $37 |
| Eisai Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| AstraZeneca | 1 | $31 |
| SK Life Science, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Abbott | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Merz Pharmaceuticals, LLC | 1 | $17 |
| Philips North America LLC | 1 | $15 |
| CSL Behring | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$2,205 in reported general payments places this provider in the 45th percentile of 308 neurology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 15 | $238 |
Paid to pharmacies, not to this prescriber.
Other neurology in Valparaiso
- Kristi GeorgeIndianapolis$10.8M
- Craig HerrmanIndianapolis$7.8M
- Martin FarlowIndianapolis$4.8M
- Jared BroschIndianapolis$4.7M
- Ajay GuptaFort Wayne$2.5M
- Christopher WilsonAvon$2M
- Alexandru BarboiIndianapolis$1.9M
- William ConteMerrillville$1.7M
- James StevensFort Wayne$1.5M
- Kathryn NevelIndianapolis$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.